The synergism between Belotecan and cisplatin in gastric cancer. - Wikidata - awgldk - TriplyDB

The synergism between Belotecan and cisplatin in gastric cancer.

The synergism between Belotecan and cisplatin in gastric cancer.

http://www.wikidata.org/entity/Q37341744

about

Phase II study of combined belotecan and cisplatin as first-line chemotherapy in patients with extensive disease of small cell lung cancer.

P2860

Q33395861-35CEADC4-9DD8-40E2-A01A-8764B191BC63

P2860

The synergism between Belotecan and cisplatin in gastric cancer.

http://www.wikidata.org/entity/Q37341744

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 September 2006

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The synergism between Belotecan and cisplatin in gastric cancer.

@en

The synergism between Belotecan and cisplatin in gastric cancer.

@nl

type

label

The synergism between Belotecan and cisplatin in gastric cancer.

@en

The synergism between Belotecan and cisplatin in gastric cancer.

@nl

prefLabel

The synergism between Belotecan and cisplatin in gastric cancer.

@en

The synergism between Belotecan and cisplatin in gastric cancer.

@nl

P1433

Q37341744-6866A1E5-4338-438F-B4ED-E385278DC66B

P1476

Q37341744-3ECCF9DB-88D7-4F5D-8B26-80FBF2401A8A

P2093

Q37341744-3F82896D-D2DF-4E93-9CE8-AC250BAECC77

Q37341744-4A449F3D-9CBC-4585-B51E-A1D16B820134

Q37341744-59FD6B7E-F226-42F2-8A4D-63F529F5363A

Q37341744-60918121-4FD4-47F0-9055-4CE6F304F82B

Q37341744-675FC549-3674-4FAA-B91C-347705C2D82C

Q37341744-6BC370D2-C32A-4524-8447-8EBBD9C619FC

Q37341744-9BB9C871-B9CC-444E-800D-E704DE9A1D0C

Q37341744-C0288806-D7A4-469A-9945-F1B33B5CEBE4

Q37341744-D2FF543B-1E4B-403A-8627-259C2399FC72

P2860

Q37341744-05392D5A-7EA6-4B99-81AA-A316F834D588

Q37341744-23ED18BB-A6C4-458C-96EF-79F4F65C0A7F

Q37341744-41468AFF-8CA6-4A58-AD31-D024C38FC241

Q37341744-4498B3AC-FA81-49F6-A616-21D17EE19655

Q37341744-46FD3D4A-2CBB-4248-A862-DAF582639FFF

Q37341744-52137772-DB7A-4F09-B163-A3E04CFF9EB4

Q37341744-586501CF-2591-4EB4-856F-783CF2162F67

Q37341744-766C253F-86F5-4492-B087-230F1D8E5458

Q37341744-7783C5A3-BDD8-4A72-A904-B362284D1CE8

Q37341744-7D8838A1-DC92-440C-9C2F-D1912F0D6E23

P304

Q37341744-831F3F19-E93D-4F1F-AF74-0914E1AD31B5

P31

Q37341744-0CB28EE0-1CDB-4A9D-9376-1CD64F332CC4

P356

Q37341744-40B2E9D5-D23C-471C-BCE9-223AFB2C9C64

P433

Q37341744-E53CCEC7-90D6-4329-A80A-8A69F38068B7

P478

Q37341744-64D6AFBF-9BAA-41BF-945E-EF12100A15C9

P577

Q37341744-DB97C17D-05A2-4C97-926E-7F43923F9920

P5875

Q37341744-406FE21B-BC66-4FC7-8EA6-052A9A901737

P698

Q37341744-B9EABEEC-9AFF-4447-8CC5-00F4C44F089E

P932

Q37341744-6EEB6399-4611-446A-A4F0-AA311C3D0CD9

P356

CRT.2006.38.3.159

P1433

Cancer Research and Treatment

P1476

The synergism between Belotecan and cisplatin in gastric cancer.

@en

P2093

Hyun-Soon Jong

http://www.w3.org/2001/XMLSchema#string

Joo Young Jung

http://www.w3.org/2001/XMLSchema#string

Jung Hyun Park

http://www.w3.org/2001/XMLSchema#string

Noe Kyoung Kim

http://www.w3.org/2001/XMLSchema#string

Sang Hyun Song

http://www.w3.org/2001/XMLSchema#string

Seock-Ah Im

http://www.w3.org/2001/XMLSchema#string

Tae-You Kim

http://www.w3.org/2001/XMLSchema#string

Tae-Young Kim

http://www.w3.org/2001/XMLSchema#string

Yung-Jue Bang

http://www.w3.org/2001/XMLSchema#string

P2860

Eukaryotic DNA topoisomerases: two forms of type I DNA topoisomerases from HeLa cell nuclei.

Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.

Synergistic cytotoxicity of cisplatin and topotecan or SN-38 in a panel of eight solid-tumor cell lines in vitro.

DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum(II).

Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair.

In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems.

Establishment and characterization of human gastric carcinoma cell lines.

Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line.

Effects of CPT-11 in combination with other anti-cancer agents in culture.

Topotecan in combination chemotherapy.

P304

159-167

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4143/CRT.2006.38.3.159

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26828641

http://www.w3.org/2001/XMLSchema#string

P698

19771277

http://www.w3.org/2001/XMLSchema#string

P932

2741676

http://www.w3.org/2001/XMLSchema#string